News headlines about Omega Healthcare Investors (NYSE:OHI) have been trending somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Omega Healthcare Investors earned a coverage optimism score of 0.24 on Accern’s scale. Accern also gave media coverage about the real estate investment trust an impact score of 44.9217659540448 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Here are some of the news headlines that may have impacted Accern’s rankings:
- Stock to Watch: Omega Healthcare Investors Inc (NYSE: OHI) – Alpha Beta Stock (alphabetastock.com)
- Omega Healthcare Investors, Inc. (NYSE:OHI) – Growth Secrets – Nasdaq Journal (press release) (nasdaqjournal.com)
- Omega Healthcare Is No SWAN – Seeking Alpha (seekingalpha.com)
- Omega Has Lowered Its Standards – Seeking Alpha (seekingalpha.com)
- Omega Healthcare Investors Inc (OHI) to Post FY2019 Earnings of $3.18 Per Share, Jefferies Group Forecasts (americanbankingnews.com)
A number of research analysts recently weighed in on the company. Hilliard Lyons lowered Omega Healthcare Investors to a “buy” rating in a report on Wednesday, November 1st. Capital One Financial reaffirmed an “equal weight” rating on shares of Omega Healthcare Investors in a report on Sunday, October 22nd. ValuEngine raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Friday, December 15th. Vetr lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 price objective on the stock. in a report on Monday, October 30th. Finally, Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, September 28th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $32.14.
In other Omega Healthcare Investors news, Director Bernard J. Korman purchased 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the completion of the acquisition, the director now owns 903,895 shares of the company’s stock, valued at approximately $25,525,994.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Craig R. Callen purchased 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were acquired at an average price of $27.38 per share, for a total transaction of $273,800.00. The disclosure for this purchase can be found here. Corporate insiders own 1.54% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
What are top analysts saying about Omega Healthcare Investors? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Omega Healthcare Investors and related companies.